Skip to main content
Laurus Labs Limited logo

Laurus Labs Limited — Investor Relations & Filings

Ticker · LAURUSLABS ISIN · INE947Q01028 LEI · 335800S8HO8QRYP3VQ26 BSE.NS Manufacturing
Open in API
Filings indexed 707 across all filing types
Latest filing 2021-02-05 Call Transcript
Country IN India
Listing BSE.NS LAURUSLABS

About Laurus Labs Limited

https://www.lauruslabs.com/

Laurus Labs Limited is a research-driven organization focused on the development and manufacturing of active pharmaceutical ingredients (APIs), finished dosage forms (FDF), and specialized synthesis services. The company operates across several key therapeutic areas, including anti-retroviral (ARV), oncology, cardiovascular, and anti-diabetic treatments. Through its contract development and manufacturing organization (CDMO) division, it provides integrated drug development solutions to global partners. The company also maintains a biotechnology segment dedicated to recombinant products. Leveraging advanced research and development capabilities alongside large-scale manufacturing infrastructure, the firm emphasizes process chemistry innovation and cost-efficient production to serve diverse global healthcare markets.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a transcript of an earnings conference call for Laurus Labs Limited for Q3 FY'21. It includes detailed discussions of quarterly financial results, business updates, segment performance, and Q&A with analysts. The presence of management commentary, financial figures for the quarter and nine months, and forward-looking statements are typical of earnings call transcripts. There is no indication that this is a formal earnings release (which is usually a short summary), nor is it an annual or interim report document. The format and content clearly match a Call Transcript (CT).
2021-02-05 English
Record Date
Regulatory Filings Classification · 90% confidence The document text contains only placeholders for images and no textual content or substantive information. It is extremely short (170 characters) and does not contain any report, announcement, or financial data. Given the lack of content, it cannot be classified as a report or announcement type. The best fit is Regulatory Filings (RNS) as a fallback category for miscellaneous or non-informative filings.
2021-02-02 English
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation Classification · 70% confidence The document is very short (594 characters) and appears to be a brief notice or summary related to an investor conference or meeting, specifically mentioning an 'Annual Investor Conference' and 'Group Meetings - Virtual NDR'. There is no detailed financial data, no full report, no audit information, or any regulatory filing content. It does not contain a transcript or detailed presentation but rather a notification or summary of an event. Given the nature of the content, it best fits the category of Investor Presentation (IP), which includes detailed presentations or materials for investors focusing on financials, strategy, and market position. Although the document is brief, it references an investor conference, which aligns with the Investor Presentation category more than any other. Confidence is moderate due to brevity but clear context.
2021-02-02 English
Investor Presentation
Regulatory Filings
2021-01-28 English
Press Release
Earnings Release Classification · 95% confidence The document is a press release announcing the financial results for the quarter and nine months ended December 31, 2020. It includes key financial highlights such as revenue growth, EBITDA, PAT, EPS, and dividend declaration. The document is dated January 28, 2021, and is addressed to stock exchanges (BSE and NSE). It contains no detailed financial statements or comprehensive analysis typical of an Interim/Quarterly Report but rather a summary of financial performance and business highlights. The document length is 8598 characters, which is sufficient for a detailed earnings release but not a full interim report. The presence of phrases like 'Press Release' and the format focusing on headline financial results and commentary from executives aligns with the definition of an Earnings Release (ER). Therefore, the document should be classified as an Earnings Release (ER). Q3 2021
2021-01-28 English
Financial Result Updates
Regulatory Filings
2021-01-28 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.